Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kevan Casey currently holds 46,215,713 shares of Oncolin Therapeutics, Inc. (OCOL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kevan Casey has been a net seller of OCOL stock. They have purchased $5.3K and sold $2.1B worth of shares.
Kevan Casey's most recent insider trade was on Aug 19, 2010, when they sold 0 shares at $0.00 per share.
Kevan Casey serves as Executive at Oncolin Therapeutics, Inc. (OCOL). They have executed 84 insider transactions totaling $2.1B over their tenure at the company.
Kevan Casey holds the position of Executive at Oncolin Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Kevan Casey has shown a selling trading pattern, with $5.3K in total purchases and $2.1B in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kevan Casey was on Nov 16, 2007, when they sold $11.3K worth of UCPI shares. This transaction involved 75,000 shares at $0.15 per share.
Kevan Casey currently owns 46,215,713 shares of Oncolin Therapeutics, Inc. (OCOL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kevan Casey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kevan Casey has 84 Form 4 filings on record as an insider at Oncolin Therapeutics, Inc..
Set alerts for Kevan Casey and 40,000+ other insiders.